|Tracks and Categories|
|Call for Abstract||10 March 2011||10 June 2011|
|Review of Abstract||15 June 2011||31 July 2011|
|Notice of Acceptance of Abstract||15 September 2011|
Call for Abstracts
16th International Conference on AIDS and Sexually Transmitted Infections in Africa
4 – 8 December 2011, Addis Ababa, Ethiopia
Call for abstract means the submission of abstracts for original contribution to the field to be presented (oral or poster presentation) during the conference, if accepted.
CLICK HERE to login to the profile, and to view and print abstracts you have already submitted.
Please read the following guidelines carefully before submitting your abstract:
- All abstracts may be written in English or French. Texts written in other alphabets other than the above two mentioned cannot be saved by the submission system.
- If you wish to submit an abstract besides the two languages specified above, we recommend that you have your abstract translated and reviewed before submission.
- Abstracts can only be submitted online via the conference website; those submitted by fax, post or e-mail will not be considered. All submissions will be acknowledged upon successful submission via the site.
- The abstract text should not exceed 500 words. This structured abstract includes the following sections: Background, Objectives, Methods, Results, Conclusions and Recommendations.
- The number of authors per abstract is unlimited. However, only one author can be listed as the presenting author.
- Use a standard font like Arial when formatting your text. This will help to prevent special characters from getting lost when copying your text to online abstract submission form. Always make sure to check the final abstract with the system’s preview function before submission, and edit or replace as necessary.
- Tables, figures, literature references, and acknowledgments should not form any part of the abstract’s content.
- It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
- Abstracts must not have been published for presentation to any other national or international meeting. However, an abstract that was submitted but was not accepted in previous conferences are valid and may be submitted for ICASA 2011.
- Define all abbreviations and concepts in your abstract at first use.
- For therapeutic agents, only generic names may be used (trade names are not permitted).
The Conference offers two options for abstract submission: OPTION 1 and 2.
The first option is most suited for scientific research. Abstracts presented under the first option should contain concise statements of:
Background: indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analyzed or evaluated.
Methods: describe the setting/location for the study, study design, study population, data collection and methods of analysis used.
Results: present as clearly and detailed as possible the findings/outcome of the study, with specific results in summarized form. Inclusion of gender breakdown of data is strongly encouraged.
Conclusions and Recommendations: briefly discuss the data and main outcome of the study. Emphasize the significance for HIV prevention, treatment, care and/or support, and future implications of the results.
The second option is most suited for presenting new knowledge or analysis that are important for understanding and responding to the HIV epidemic and its future implications. It is suited for information that was gained through systematic forms of knowledge production/ management, by means other than scientific research or evaluation including community level experiences and best practices in response to HIV and AIDS. This process must include some evidence provided through some data obtained.
Abstracts presented under the second option should contain concise statements of:
Issues: a summary of the issue(s) addressed by the abstract.
Description: a description of the intervention, project, experience, service and/or advocacy.
Lessons learned: conclusions and implications of the intervention or project. Data that support the lessons learned and evidence must be included.
Next steps: possible next steps for implementation, or recommendations.
We encourage work that introduces new ideas and conceptualizations, research and understandings to the field, as well as analysis of both success and failure.
Abstracts should disclose primary findings and avoid, whenever possible, promissory statements such as "experiments are in progress" or "results will be discussed".
Your abstract, if accepted, will appear in its full form in the abstract book, and/or on the abstract CD-ROM and on the conference and ICASA website. The CD-ROM will be distributed to all registered delegates at the conference.
Abstracts Submitted after the Deadline
A small number of abstracts submitted after the regular deadline will be accepted. The percentage of abstracts selected for late submittals will depend on the number of submissions. If at all possible, abstracts should be submitted by the regular deadline and the late submittals should be reserved for data that is indeed not available before the deadline of 10 June 2011. This rule applies for regular abstracts, posters and presentations.
Please note that a presenting author that submitted his/her abstracts late are only allowed to present ONE of the late submitted abstract at the conference, in addition to any previously accepted abstracts. The late breaker abstract submission will be open 19 September - 17 October 2011.
ICASA Abstract Transparency Policy
An abstract can be submitted and may be accepted although it has been previously published or presented at a national, regional or international meeting, provided that there are new methods, new findings, updated information or other valid reasons for submitting that can be provided by the author.
If preliminary or partial data has been published or presented, the author is required to indicate the details of that conference, meeting or journal and the reasons for submitting the abstract to this conference. This information will be considered by the Scientific Program Committee when making final decisions.
Gender Analysis in Abstracts
Inclusion of gender breakdown of data is strongly encouraged, and should be provided as well as a comprehensive gender analysis in the results section whenever possible. If applicable, your abstract should include the number and percentage of men and women who participated in your research or project, and gender disaggregated data. If your research or project was specific to one gender, please state.
Choosing Abstract Track Categories
The abstract track category is the general heading under which your abstract will be reviewed and later published in the conference printed matters, if accepted. Please choose the category which best describes the subject of your abstract. Refer to the Tracks and Categories page of the website to get more information.
ICASA 2011 has identified a number of cross-cutting themes, with relevance across the five tracks. These cross-cutting themes will help structure the whole program of the conference and will serve as a basis for interdisciplinary sessions conveying presentations from various tracks and disciplines on relevant issues. In addition to choosing the track category, you may also indicate that is relevant to your abstract.
In addition to the abstract category, please indicate 3-5 keywords (free text, maximum 25 characters per keyword) in bold at the bottom of your abstract. The key words must be representative to the content of the abstract. If relevant, please specify subject/population, setting/location and objective/outcome.
ICASA Conference Profile
Before you can submit an abstract, you need to create a Conference profile from which you can enter the abstract system. You can submit one or several abstracts from your Conference profile. After an abstract has been created, modifications can be made until the abstract submission deadline. No modifications can be made once the abstract has been submitted.
Abstract Blinding and Review
All submitted abstracts will go through a blind peer-review process carried out by a reviewing committee. Each abstract will be reviewed by at least three reviewers.
Notification of Acceptance or Rejection to Corresponding Author
Notification of acceptance or rejection will be sent to the submitting (corresponding) author by 15 September 2011. Please note that onlythe corresponding author will receive email concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract. The decision of the Scientific Program Committee is final and appeals will not be considered.
Rule of Five
Each presenting author may present a maximum of five abstracts at the conference. The number of submissions is, however, not limited.
ICASA Young Investigator Award
To encourage young researchers and to recognize excellence, ICASA 2011 will present the Young Investigator Award in each track. To be eligible, the presenting author of an abstract must be no older than 35 years of age on 10 June 2011. The prize supports young researchers who demonstrate excellence in the area of research programs related to the scale up of prevention and treatment interventions in resource-limited settings. To be eligible for nomination, presenting authors of the abstract must be no older than 35 years of age on 10 June 2011 and is a citizen of a low/middle income country (according to the World Bank classification). The research must have been carried out in a low/middle income country and must, directly or indirectly, be related to increasing access to prevention and/or treatment in resource-constrained settings. A prize of US $3,000 will be given to the highest scoring abstract which meets the above criteria for each of the conference tracks.
The Young Investigator Prize: Women, Girls and HIV and AIDS
This prize will be awarded to a young woman investigator from a resource-limited setting whose abstract most demonstrates excellence in research and/or practice that address women, girls and gender issues related to HIV and AIDS. To be eligible, the presenting author must be a woman, from a low/middle income country (according to the World Bank classification), no older than 35 years of age on 10 Junemay 2011, and the investigation must have taken place in a low/middle income country. An award of US $3,000 will be awarded by ICASA 2011.
Scholarship Application ProcessScholarship applications are now closed.
Tracks and Categories
Track A: Biology and Pathogenesis of HIV
Scope and Objectives
This track will encompass all aspects of fundamental HIV biology and the host response to HIV. Areas of focus will include HIV infection and replication, transmission, genetics, evolution, structure and function, pathogenesis, adaptive and innate immune responses to HIV, genetic susceptibility to HIV, interaction of micronutrients, co-infection and progress in animal models. Pre-clinical vaccine, microbicide, and drug development will be important themes of this track.
Track B: Clinical Research, Treatment and Care
Scope and Objectives
This track will highlight the latest research findings, complexities and controversies related to the diagnosis, natural history and management of HIV infection; prevention, diagnosis and treatment of opportunistic infections; co-infection and other co-morbidities; antiretroviral therapy and immunotherapy. Issues for discussion related to antiretroviral therapy will include new drug therapies, pharmacokinetics, drug interactions, adherence and retention in care including pre-ART care, short- and long-term adverse events, clade types and drug resistance. Approaches to treatment, care and support in specific populations including infants and children, adolescents, women (including prevention of mother-to-child transmission) and marginalized groups and innovations related to diagnosis and to provision of HIV care in resource-limited settings will be addressed.
Track C: Epidemiology, Prevention and Prevention Research
Scope and Objectives
This track will focus on HIV/AIDS prevention research and issues related to the design, implementation and evaluation of prevention programs. It will include examination of methodological and programmatic advances in the continuum of prevention research, particularly best practices in HIV prevention for vulnerable populations in resource-limited settings. Strategies to put HIV prevention research into practice, efforts to promote preparedness for bio-medical prevention technologies, and research on new prevention approaches including microbicides, vaccines, pre- and post exposure prophylaxis, circumcision and other methods will be presented.
Track D: Social and Behaviour Sciences
Scope and Objectives
This track aims to highlight new knowledge and address gaps in the translation of behavioural and social science evidence into practice, and to contribute to the building of theory and understanding in HIV-related social science. The track also aims to promote understanding of the individual and social determinants of HIV-related risk, vulnerability and impact, to inform development of effective and sustainable HIV responses.
This track will feature research, analysis and evaluation on psychosocial factors that shape individual attitudes, experiences, and behaviours; social and structural factors that shape vulnerability and risk; social and cultural norms that underlie individual risk and community vulnerability; programmes that promote access to HIV and STI prevention, treatment, care and support; social and structural factors that shape vulnerability; and methods and outcomes of individual and community engagement, leadership, empowerment, and self-determination.
Track E: Policy, Program and Health Economics
Scope and Objectives
This track will analyze the quality of health systems in the context of the decentralization of treatment and care, as well as the funding of those systems. At the same time, issues related to health economics, integration of health programs, and the role and responsibilities of media will be discussed. Ethics and human rights are also important issues in sharing experiences of HIV and AIDS and STI management
In addition, there will be oral non-abstract, moderated presentations on topics of current and future significance to the HIV and STIs response in Africa. Please submit a non-structured summary in no more than 300 words related to the above subject.